I had previously looked at Grail and the Galleri test and understood then (approx 12-18 months ago) that the sensitivity for early stages is poor. Just did a quick google then and came up with the below.
I think IIQ's SubB2M is still in with a very good chance. DYOR of course.
https://www.health.com/condition/cancer/galleri-cancer-blood-test
Ann: Appendix 4E and Preliminary Financial Report, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.0¢ |
Change
-0.010(1.79%) |
Mkt cap ! $58.03M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 56.0¢ | 55.0¢ | $25.44K | 46.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 23792 | 54.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.0¢ | 15741 | 1 |
View Market Depth
| Last trade - 14.38pm 02/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |